The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|33|5022-5032

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.33, 2011-11, pp. : 5022-5032

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of taxanes in the treatment of breast cancer

By Nabholtz Jean-Marc   Gligorov Joseph  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1073-1094

Informa Healthcare

Access to resources Recommend Favorite

Letrozole: present and future role in the treatment of breast cancer

By Amar Surabhi   Roy Vivek   Perez Edith A  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 12, 2007-08 ,pp. : 1965-1975

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitors and other novel agents in breast cancer treatment

By Saji Shigehira   Toi Masakazu  

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 303-319

Informa Healthcare

Access to resources Recommend Favorite

Resveratrol and Its Analogs As Antitumoral Agents For Breast Cancer Treatment

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-06 ,pp. : 699-709

Bentham Science Publishers

Access to resources Recommend Favorite

Current and Potential Chemotherapeutic Agents Used for Induction Chemotherapy in the Treatment of Breast Cancer

By  

Current Pharmaceutical Design, Vol. 6, Iss. 3, 2000-02 ,pp. : 327-343

Bentham Science Publishers

Access to resources Recommend Favorite